OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schizophrenia
Michael J. Owen, Akira Sawa, Preben Bo Mortensen
The Lancet (2016) Vol. 388, Iss. 10039, pp. 86-97
Open Access | Times Cited: 1568

Showing 1-25 of 1568 citing articles:

The Microbiota-Gut-Brain Axis
John F. Cryan, Kenneth J. O’Riordan, Caitlin S.M. Cowan, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1877-2013
Open Access | Times Cited: 3429

Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Vassily Trubetskoy, Antonio F. Pardiñas, Ting Qi, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 502-508
Open Access | Times Cited: 1799

Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
Antonio F. Pardiñas, Peter Holmans, Andrew Pocklington, et al.
Nature Genetics (2018) Vol. 50, Iss. 3, pp. 381-389
Open Access | Times Cited: 1528

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 804

Influence of gut microbiota on neuropsychiatric disorders
María Carmen Cénit, Yolanda Sanz, Pilar Codoñer‐Franch
World Journal of Gastroenterology (2017) Vol. 23, Iss. 30, pp. 5486-5486
Open Access | Times Cited: 371

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Justin Davis, Harris A. Eyre, Felice N. Jacka, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 185-194
Open Access | Times Cited: 322

Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia
Stephan Ripke, James Walters, Michael O’Donovan
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 318

Schizophrenia and the neurodevelopmental continuum:evidence from genomics
Michael J. Owen, Michael O’Donovan
World Psychiatry (2017) Vol. 16, Iss. 3, pp. 227-235
Open Access | Times Cited: 286

Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Dag Alnæs, Tobias Kaufmann, Dennis van der Meer, et al.
JAMA Psychiatry (2019) Vol. 76, Iss. 7, pp. 739-739
Open Access | Times Cited: 247

The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Aleksandra Góralczyk-Bińkowska, Dagmara Szmajda‐Krygier, Elżbieta Kozłowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11245-11245
Open Access | Times Cited: 237

Cannabis use and risk of schizophrenia: a Mendelian randomization study
Julien Vaucher, Brendan J. Keating, Aurélie M. Lasserre, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 5, pp. 1287-1292
Open Access | Times Cited: 228

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability
Tarjinder Singh, James Walters, Mandy Johnstone, et al.
Nature Genetics (2017) Vol. 49, Iss. 8, pp. 1167-1173
Open Access | Times Cited: 227

Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence
Olav B. Smeland, Shahram Bahrami, Oleksandr Frei, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 4, pp. 844-853
Open Access | Times Cited: 209

Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
Merel M.J. van den Berg, Julian Krauskopf, Johannes G. Ramaekers, et al.
Progress in Neurobiology (2019) Vol. 185, pp. 101732-101732
Open Access | Times Cited: 208

Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Tina Notter, Jennifer M. Coughlin, Tilo Gschwind, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 2, pp. 323-334
Open Access | Times Cited: 181

Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk
Adrianna P. Kępińska, Conrad Iyegbe, Anthony C. Vernon, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 179

Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 168

The role of histone modifications: from neurodevelopment to neurodiseases
Jisu Park, Kyubin Lee, Kyunghwan Kim, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 156

Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders
Laura Mitrea, Silvia Amalia Nemeş, Katalin Szabo, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 153

Spine dynamics in the brain, mental disorders and artificial neural networks
Haruo Kasai, Noam Ziv, Hitoshi Okazaki, et al.
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 7, pp. 407-422
Closed Access | Times Cited: 147

Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders
Somarani Dash, Yasir Ahmed Syed, Mojibur R. Khan
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 106

Impact of Advanced Paternal Age on Fertility and Risks of Genetic Disorders in Offspring
Aris Kaltsas, Efthalia Moustakli, Athanasios Zikopoulos, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 486-486
Open Access | Times Cited: 86

Neurobiology of Schizophrenia: A Comprehensive Review
Enkhmaa Luvsannyam, Molly S Jain, Maria Kezia Lourdes Pormento, et al.
Cureus (2022)
Open Access | Times Cited: 78

Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants
Giovanni Ostuzzi, Federico Bertolini, Federico Tedeschi, et al.
World Psychiatry (2022) Vol. 21, Iss. 2, pp. 295-307
Open Access | Times Cited: 77

Page 1 - Next Page

Scroll to top